Different studies have shown conflicting results about the association of ELAC2 variants and prostate cancer risk, suggested to be due to differences in ethnicity of individuals as well as environmental and lifestyle factors (Camp & Tavtigian, 2002; Studeny et al, 2002; Severi et al, 2003; Xu et al, 2010; Djomkam et al, 2020). This evidence concerns the gene ELAC2 and prostate carcinoma.